Literature DB >> 18766116

Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma.

Justin M M Cates1, Robert H Byrd, Laurel E Fohn, Armanda D Tatsas, Mary K Washington, Candice C Black.   

Abstract

OBJECTIVES: Expression of transcription factors that mediate epithelial-mesenchymal transition (EMT), such as Twist and Slug, is correlated with poor prognosis in many tumor types. Selected EMT markers were studied in a series of pancreatic ductal adenocarcinomas (PDAs) and benign pancreatic tissues to determine whether expression levels correlated with diagnosis, histologic grade, or patient outcome.
METHODS: Immunohistochemical stains for Twist, Slug, and N-cadherin were performed using a tissue microarray containing 68 PDAs and 38 samples of normal pancreas or chronic pancreatitis tissues.
RESULTS: Twist and Slug were identified in both the nucleus and cytoplasm of benign pancreatic ductal epithelium, chronic pancreatitis, and PDA. Compared with normal ductal epithelium, nuclear levels of Twist are decreased in PDA. None of the other EMT markers showed significant differences in staining indices among the diagnostic groups. There were no correlations between EMT marker expression and histologic grade. Epithelial-mesenchymal transition marker expression was not associated with N-cadherin expression, patient outcome, or duration of survival.
CONCLUSIONS: Decreased expression of nuclear Twist is observed in malignant pancreatic epithelium. However, use of Twist as a diagnostic marker is precluded because decreased expression is also seen in chronic pancreatitis. None of the markers studied were predictive of patient outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18766116      PMCID: PMC2882851          DOI: 10.1097/MPA.0b013e3181878b7f

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  40 in total

Review 1.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

2.  Significance of TWIST expression and its association with E-cadherin in bladder cancer.

Authors:  Zheng Zhang; Dan Xie; Xin Li; Yogn-Chuan Wong; Dianqi Xin; Xin-Yuan Guan; Chee Wai Chua; Steve C L Leung; Yanqun Na; Xianghong Wang
Journal:  Hum Pathol       Date:  2007-01-29       Impact factor: 3.466

3.  Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.

Authors:  H-F Yuen; C-W Chua; Y-P Chan; Y-C Wong; X Wang; K-W Chan
Journal:  Histopathology       Date:  2007-04       Impact factor: 5.087

Review 4.  Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment.

Authors:  Joyce C Tse; Raghu Kalluri
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

5.  Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.

Authors:  Hiu-Fung Yuen; Yuen-Piu Chan; Michelle Lok-Yee Wong; Wei-Kei Kwok; Ka-Kui Chan; Pin-Yin Lee; Gopesh Srivastava; Simon Ying-Kit Law; Yong-Chuan Wong; Xianghong Wang; Kwok-Wah Chan
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

6.  Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin.

Authors:  C Castro Alves; E Rosivatz; C Schott; R Hollweck; I Becker; M Sarbia; F Carneiro; K-F Becker
Journal:  J Pathol       Date:  2007-04       Impact factor: 7.996

Review 7.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

8.  Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression.

Authors:  Zhou Yang; Xiaohong Zhang; Haiju Gang; Xiaojun Li; Zumao Li; Tao Wang; Juan Han; Ting Luo; Fuqiang Wen; Xiaoting Wu
Journal:  Biochem Biophys Res Commun       Date:  2007-05-15       Impact factor: 3.575

9.  Expression of snail in pancreatic cancer promotes metastasis and chemoresistance.

Authors:  Tao Yin; Chunyou Wang; Tao Liu; Gang Zhao; Yunhong Zha; Ming Yang
Journal:  J Surg Res       Date:  2007-06-20       Impact factor: 2.192

10.  Markers of epithelial-mesenchymal transition and epithelial differentiation in sarcomatoid carcinoma: utility in the differential diagnosis with sarcoma.

Authors:  Justin M M Cates; William D Dupont; Jason W Barnes; Hayward S Edmunds; John H Fasig; Sandra J Olson; Candice C Black
Journal:  Appl Immunohistochem Mol Morphol       Date:  2008-05
View more
  40 in total

1.  Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Authors:  Wei Li; Jiguang Ma; Qingyong Ma; Bin Li; Liang Han; Jiangbo Liu; Qinhong Xu; Wanxing Duan; Shuo Yu; Fengfei Wang; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

2.  Accomplishments in 2008 in the treatment of metastatic pancreatic cancer.

Authors:  Volker Heinemann; Philip A Philip; Uwe Pelzer
Journal:  Gastrointest Cancer Res       Date:  2009-09

3.  Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway.

Authors:  Zimin Liu; Jian Zhang; Guangchen Hong; Jinping Quan; Lin Zhang; Meiqin Yu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

4.  Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis.

Authors:  Nagathihalli S Nagaraj; J Joshua Smith; Frank Revetta; M Kay Washington; Nipun B Merchant
Journal:  Mol Cancer Ther       Date:  2010-08-03       Impact factor: 6.261

5.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Authors:  Nagaraj S Nagathihalli; Yugandhar Beesetty; Wooin Lee; M Kay Washington; Xi Chen; A Craig Lockhart; Nipun B Merchant
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

6.  Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.

Authors:  Nagaraj S Nagathihalli; Jason A Castellanos; Chanjuan Shi; Yugandhar Beesetty; Michelle L Reyzer; Richard Caprioli; Xi Chen; Alex J Walsh; Melissa C Skala; Harold L Moses; Nipun B Merchant
Journal:  Gastroenterology       Date:  2015-08-07       Impact factor: 22.682

7.  Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer.

Authors:  Yi Tan; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2012-12-06

8.  Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells.

Authors:  Yoshihide Shimojo; Miho Akimoto; Tsunehiro Hisanaga; Tsuneo Tanaka; Yoshitsugu Tajima; Yoshio Honma; Keizo Takenaga
Journal:  Clin Exp Metastasis       Date:  2012-07-26       Impact factor: 5.150

9.  The Epithelial-to-Mesenchymal Transition (EMT) in Development and Cancer.

Authors:  Alexandre Francou; Kathryn V Anderson
Journal:  Annu Rev Cancer Biol       Date:  2019-11-25

Review 10.  Pancreatic cancer stem cells and EMT in drug resistance and metastasis.

Authors:  F H Sarkar; Y Li; Z Wang; D Kong
Journal:  Minerva Chir       Date:  2009-10       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.